Strengthening Families & Communities LLC’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-533
Closed -$37.5K 629
2025
Q3
$37.5K Buy
+533
New +$31.2K 0.01% 266
2025
Q2
Sell
-124
Closed -$17.7K 424
2025
Q1
$17.7K Buy
+124
New +$10.2K 0.01% 211
2024
Q4
Sell
-525
Closed -$62.5K 489
2024
Q3
$62.5K Buy
525
+1
+0.2% +$133 0.02% 220
2024
Q2
$75K Buy
+524
New +$69.4K 0.02% 215
2023
Q4
Sell
-3,084
Closed -$280K 338
2023
Q3
$280K Sell
3,084
-592
-16% -$52.1K 0.12% 121
2023
Q2
$297K Buy
+3,676
New +$300K 0.13% 122

Other funds holding NVO

Strengthening Families & Communities LLC's NVO Position: Q4 2025 in Review

Strengthening Families & Communities LLC sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 533 shares — an estimated $37.5K sold.

Strengthening Families & Communities LLC first reported a position in NVO in Q2 2023 and held it in 6 quarters. The position peaked at $297K in Q2 2023. 1,418 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Strengthening Families & Communities LLC reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Strengthening Families & Communities LLC sold 533 Novo Nordisk shares in Q4 2025, an estimated $37.5K.
  • Strengthening Families & Communities LLC first reported a position in Novo Nordisk in Q2 2023 and held it in 6 quarters.
  • Strengthening Families & Communities LLC's Novo Nordisk position peaked at $297K in Q2 2023.
  • 1,418 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Strengthening Families & Communities LLC's 13F filing for Q4 2025, filed 3 Feb 2026.